SCOPUS 정보 검색 플랫폼

Volumn 63, Issue 6, 1977, Pages 897-903

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

(3) Case Jr , Delvyn C a Lee III, Burton J a Clarkson, Bayard D a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; MELPHALAN; PREDNISONE; PROCARBAZINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL STUDY; DRUG COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; THERAPY; THYMIDINE H 3;

ANTINEOPLASTIC AGENTS; CARMUSTINE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MELPHALAN; MIDDLE AGE; MULTIPLE MYELOMA; PREDNISONE; REMISSION, SPONTANEOUS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; VINCRISTINE;

EID: 0017763310 PISSN: 00029343 EISSN: None Source Type: Journal
DOI: 10.1016/0002-9343(77)90543-5 Document Type: Article

Times cited : (160)

References (31)

1
- 0014661330
- Treatment for multiple myeloma
- (1969) JAMA , vol.208 , pp. 1680
- Alexanian¹ Haut² Khan³

2
- 0017050672
- Melphalan treatment of multiple myeloma
- (1976) Memorial Sloan-Kettering Cancer Center Bulletin , vol.6 , pp. 142
- Pinsky¹ Lee²

3
- 0015381240
- Combination chemotherapy for multiple myeloma
- (1972) Cancer , vol.30 , pp. 383
- Alexanian¹ Bonnet² Gehan³

4
- 0015455041
- Plasma cell myeloma. An interpretive review
- (1972) Cancer , vol.30 , pp. 1588
- Bersagel¹

5
- 0015494146
- Plasma cell myeloma: Response of melphalan-resistant patients to high-dose intermittent cyclophosphamide
- (1972) J Can Med Assoc , vol.107 , pp. 851
- Bersagel¹ Cowan² Hasselback³

6
- 0001653947
- Multiple myeloma II. Analysis of cyclophosphamide therapy in 165 patients
- (1964) JAMA , vol.189 , pp. 758
- Korst¹ Clifford² Fowler³

7
- 0014681863
- Cyclophosphamide vs. melphalan in the treatment of plasma cell myeloma
- (1969) JAMA , vol.207 , pp. 1328
- Rivers¹ Patno²

8
- 0000786623
- Comparison of effects of cylophosphamide and a placebo in the treatment of multiple myeloma
- (1963) Cancer Chemother Rep , vol.29 , pp. 115
- Rivers¹ Whittington² Patno³

9
- 0014827053
- Procarbazine and multiple myeloma
- (1970) Cancer Chemother Rep , vol.54 , pp. 245
- Moon¹ Edmonson²

10
- 0014118435
- Clinical trials with N-ios-propyl-a-(2-methyl-hydrazine)-p-toluamide hydrochloride (Natulan) in malignant lymphoma and other disseminated neoplasia
- (1967) Cancer , vol.20 , pp. 1187
- Samuels¹ Leary² Alexanian³

11
- 0017273268
- Adriamycin-BCNU chemotherapy for multiple myeloma in relapse
- (1976) Lancet , vol.1 , pp. 926
- Alberts¹ Durie² Salmon³

12
- 0016733749
- Adriamycin in the treatment of alkylator-resistant multiple myeloma. A pilot study
- (1975) Cancer Chemother Rep , vol.59 , pp. 345
- Alberts¹ Salmon²

13
- 0016436043
- Expansion of the growth fraction in multiple myeloma with alkylating agents
- (1975) Blood , vol.45 , pp. 119
- Salmon¹

14
- 0016440794
- Cellular kinetics in multiple myeloma. A new approach to staging and treatment
- (1975) Arch Intern Med , vol.135 , pp. 131
- Salmon¹ Durie²

15
- 84942561660
- Remission maintenance therapy for multiple myeloma
- (1975) Arch Intern Med , vol.135 , pp. 147
- Alexanian¹ Balzerak² Haut³

16
- 0016153826
- Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone and BCNU
- (1974) Cancer , vol.33 , pp. 533
- Lee¹ Sahakian² Clarkson³

17
- 0014801558
- Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma
- (1970) J Clin Invest , vol.49 , pp. 114
- Salmon¹ Smith²

18
- 0015367243
- Kinetics of tumor growth and regression in IgG multiple myeloma
- (1972) J Clin Invest , vol.51 , pp. 1697
- Sullivan¹ Salmon²

19
- 0016804136
- A clinical staging system for multiple myeloma
- (1975) Cancer , vol.36 , pp. 842
- Durie¹ Salmon²

20
- 0016774995
- Prognostic factora in multiple myeloma
- (1975) Cancer , vol.36 , pp. 1192
- Alexanian¹ Balzerak² Bonnet³

21
- 0001292684
- Proposed guidelines for protocol studies. II. Plasma cell myeloma
- (1973) Cancer Chemother Rep , vol.4 , pp. 145
- Myeloma Task Force¹ National Cancer Institute²

22
- 33845382806
- Non-parametric estimation from incomplete observations
- (1958) Journal of the American Statistical Association , vol.53 , pp. 457
- Kaplan¹ Meier²

23
- 84951601829
- A generalized Wilcoxan test for comparing arbitrarily singly-censored samples
- (1965) Biometrika , vol.52 , pp. 302
- Gehan¹

24
- 0016438485
- Treatment of plasma cell myeloma with cytotoxic agents
- (1975) Arch Intern Med , vol.135 , pp. 172
- Bergsagel¹ Pruzanski²

25
- 0015858832
- Prognosis of myelomatosis on treatment with prednisone and cytostatics
- (1973) Scand J Haemat , vol.10 , pp. 282
- Hansen¹ Jessen² Videback³

26
- 0014533013
- Growth rates and responses to treatment in human myelomatosis
- (1969) Br J Haematol , vol.16 , pp. 607
- Hobbs¹

27
- 0015830795
- Immunoglobulin synthesis and tumor kinetics of multiple myeloma
- 2nd ed
- (1973) Semin Hematol , vol.10 , pp. 135
- Salmon¹

28
- 0016295145
- Perturbation of DNA synthesis in multiple myeloma cell, following cell cycle-nonspecific chemotherapy
- (1974) Cancer Res , vol.34 , pp. 2911
- Alberts¹ Golde²

29
- 0016110256
- Effect of chemotherapy on the labelling index of myeloma cells
- (1974) Cancer , vol.34 , pp. 526
- Drewinko¹

30
- 84912258397
- Pileri A, Bernengo MG, Boccadoro M, et al.: Early recruitment in human myeloma population after cytostatic treatment. Haematologica (in press).

31
- 84912250265
- Induction of tumor susceptibility to cycle-active agents in IgG multiple myeloma
- (1972) Clin Res , vol.20 , pp. 570
- Salmon¹ Smith²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.